Roche stock price ends week higher — dividend vote and 2026 outlook set the tone for Monday
Roche shares closed Friday 1.1% higher at CHF 350.70, building on a two-day rally following volatile trading around its annual results.
Roche stock price slips into the weekend — here’s what could move shares on Monday
Roche slid 0.64% on Friday to finish at 356.40 Swiss francs, with no new headlines out to move the stock ahead of the weekend. Shares ranged from 352.50 to 357.20 francs, volume landing at roughly 766,000.
Company hubSWX:ROG
Roche (ROG) Stock News & Analysis
Follow the latest Roche (ROG) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 14
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
Eli Lilly stock price falls over 2% as Medicare puts Trulicity on 2028 price-talk list
Eli Lilly and Company shares ended Tuesday down $24.22, or roughly 2.3%, at $1,039.51. In after-hours trading, the stock edged up about 0.3% to $1,042.50. The U.S. Centers for Medicare & Medicaid Services announced it selected Lilly’s Trulicity, a type 2 diabetes drug, along with 14 other medicines for 2028 price negotiations. This marks the first time the list includes some therapies covered under Medicare Part B. Last year, the agency projected that negotiated prices for the 15 drugs chosen for 2027 would cut annual spending by 36%, roughly $8.5 billion, compared to recent costs.
Roche stock hovers near a 52-week high as investors brace for Thursday’s results
Roche Holding participation shares edged up on Friday, hovering near a 52-week high ahead of the Swiss pharma giant’s full-year earnings release this week. The stock closed at 348.10 Swiss francs, gaining 0.06%, after fluctuating between 344.90 and 349.50 during the session, just shy of its one-year peak at 349.70.
ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
ImmunityBio, Inc. shares closed Friday down 12.1% at $6.45, having traded as high as $7.88 and as low as $6.43 amid heavy volume.
Roche stock price holds near a 52-week high as Jan. 29 results near — what to watch next week
Roche Holding’s non-voting shares ended Friday at 348.10 Swiss francs, rising 0.20 franc. The stock hovered just shy of its 52-week peak during the session.
Roche stock in focus: Goldman flips to Neutral, UBS lifts target as Jan 29 results loom
Roche Holding Ltd’s non-voting shares ended Friday up 0.93%, closing at 348.90 Swiss francs. The stock has remained within a narrow band heading into Monday’s session.
Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus
Shares of Structure Therapeutics climbed roughly 14% on Tuesday, adding to the stock’s recent swings. The move came as investors took a fresh look at the company’s newly announced patent licensing deal with Roche’s Genentech.
Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus
Roche Holding shares rose 0.4% on Friday following news that China’s MediLink Therapeutics inked a licensing deal with the Swiss pharma giant for an experimental cancer drug. The stock closed at 340.80 Swiss francs on the SIX Swiss Exchange.
Swiss Stock Market Outlook Today (9 December 2025): Roche Catalysts, SNB Rate Bets and Fed Jitters Set the Tone
Zurich’s stock market is heading into Tuesday’s session with the Swiss Market Index hovering just under the symbolic 13,000 level, as investors juggle a powerful mix of bullish news from Roche, cautious analyst calls on financials and industrials, and a high‑stakes week for central banks led by the Swiss National Bank and the U.S. Federal Reserve.
Swiss Stock Market Today, 21 November 2025: SMI Holds Near Flat as Tech Slides and Defensives Lift Zurich
The Swiss stock market opened under pressure on Friday but quickly stabilised, with the Swiss Market Index hovering just above the previous day’s close as investors rotated out of high‑flying tech names and into defensive blue chips.
EU Stock Market Today (18 November 2025): STOXX 600 Tumbles 1.8% as AI Bubble Fears Rattle European Shares
European equity markets slumped on Tuesday, 18 November 2025, in a broad risk-off move that dragged the pan‑European STOXX 600 to its worst daily loss since August and a one‑month low. Concerns over an overheated AI trade, fading hopes of a near‑term U.S. Federal Reserve rate cut, and fresh policy headlines from Brussels combined to knock sentiment across the EU stock market today. The Economic Times+1
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets
European equities seesawed over the two days, buffeted by transatlantic trade tensions and shifting rate expectations. On Thursday Sept. 25, the STOXX Europe 600 index dropped 0.7%, touching levels not seen in three weeks reuters.com. Almost every major bourse closed in the red reuters.com as traders digested a slew of worrying signals: fresh U.S. trade investigations into high-tech imports, surprisingly robust U.S. economic data, and guarded comments from central bankers. By Friday Sept. 26, however, markets regained footing – the STOXX 600 ticked up roughly +0.3% by midday reuters.com and was on track to finish the eventful week slightly higher brecorder.com. The late-week relief came as investors pivoted to bargain-hunting in financial and industrial shares and awaited key U.S. inflation data for clues on interest rates reuters.com.
Top 100 Global Biotechnology Companies Revolutionizing Science and Health
Biotechnology is at the forefront of scientific innovation in 2025, driven by companies around the world that are transforming healthcare, agriculture, and industry. This report profiles 100 of the most important global biotechnology companies selected for their global impact, innovation, revenue, scientific breakthroughs, and sector influence. These companies span biopharmaceutical giants, genomics and diagnostics pioneers, agricultural and environmental biotech leaders, industrial biotech innovators, and key providers of biotech tools and services. Each entry includes the company’s headquarters country, primary sector, notable contributions or innovations, and a link to its official website. The list encompasses both publicly traded and private firms, reflecting the worldwide landscape of biotech innovation.
TechStock² Updates
